Literature DB >> 25398943

Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington's disease.

Kuan-Yu Liu1, Yu-Chiau Shyu2, Brett A Barbaro3, Yuan-Ta Lin4, Yijuang Chern5, Leslie Michels Thompson6, Che-Kun James Shen7, J Lawrence Marsh8.   

Abstract

Accumulation of N-terminal fragments of mutant huntingtin (mHTT) in the cytoplasm, nuclei and axons of neurons is a hallmark of Huntington's disease (HD), although how these fragments negatively impact neurons remains unclear. We followed the distribution of mHTT in the striata of transgenic R6/2-J2 HD mice as their motor function declined. The fraction of cells with diffuse, perinuclear or intranuclear mHTT changed in parallel with decreasing motor function. In transgenic mice, medium spiny neurons (MSNs) that exhibited perinuclear inclusions expressed cell-cycle markers typically not seen in the striata of normal mice, and these cells are preferentially lost as disease progresses. Electron microscopy reveals that perinuclear inclusions disrupt the nuclear envelope. The progression of perinuclear inclusions being accompanied by cell-cycle activation and culminating in cell death was also observed in 1° cortical neurons. These observations provide a strong correlation between the subcellular location of mHTT, disruption of the nucleus, re-entry into the cell-cycle and eventual neuronal death. They also highlight the fact that the subcellular distribution of mHTT is highly dynamic such that the distribution of mHTT observed depends greatly on the stage of the disease being examined.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25398943      PMCID: PMC4381756          DOI: 10.1093/hmg/ddu574

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  70 in total

1.  Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.

Authors:  I Vincent; G Jicha; M Rosado; D W Dickson
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

2.  Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract.

Authors:  Y P Goldberg; D W Nicholson; D M Rasper; M A Kalchman; H B Koide; R K Graham; M Bromm; P Kazemi-Esfarjani; N A Thornberry; J P Vaillancourt; M R Hayden
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

Review 3.  What have we learned from gene expression profiles in Huntington's disease?

Authors:  Tamara Seredenina; Ruth Luthi-Carter
Journal:  Neurobiol Dis       Date:  2011-07-12       Impact factor: 5.996

4.  Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease.

Authors:  T Arendt; L Rödel; U Gärtner; M Holzer
Journal:  Neuroreport       Date:  1996-11-25       Impact factor: 1.837

5.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

Review 6.  Influence of species differences on the neuropathology of transgenic Huntington's disease animal models.

Authors:  Xiao-Jiang Li; Shihua Li
Journal:  J Genet Genomics       Date:  2012-05-14       Impact factor: 4.275

7.  Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

Authors:  L Mangiarini; K Sathasivam; M Seller; B Cozens; A Harper; C Hetherington; M Lawton; Y Trottier; H Lehrach; S W Davies; G P Bates
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

8.  Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts.

Authors:  Akira Sawa; Eiichiro Nagata; Siobhan Sutcliffe; Pratima Dulloor; Matthew B Cascio; Yuji Ozeki; Sophie Roy; Christopher A Ross; Solomon H Snyder
Journal:  Neurobiol Dis       Date:  2005-11       Impact factor: 5.996

9.  Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.

Authors:  S W Davies; M Turmaine; B A Cozens; M DiFiglia; A H Sharp; C A Ross; E Scherzinger; E E Wanker; L Mangiarini; G P Bates
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

10.  p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death.

Authors:  Geir Bjørkøy; Trond Lamark; Andreas Brech; Heidi Outzen; Maria Perander; Aud Overvatn; Harald Stenmark; Terje Johansen
Journal:  J Cell Biol       Date:  2005-11-14       Impact factor: 10.539

View more
  33 in total

1.  Long Term Aggresome Accumulation Leads to DNA Damage, p53-dependent Cell Cycle Arrest, and Steric Interference in Mitosis.

Authors:  Meng Lu; Chiara Boschetti; Alan Tunnacliffe
Journal:  J Biol Chem       Date:  2015-09-25       Impact factor: 5.157

Review 2.  The roles of the nuclear pore complex in cellular dysfunction, aging and disease.

Authors:  Stephen Sakuma; Maximiliano A D'Angelo
Journal:  Semin Cell Dev Biol       Date:  2017-05-12       Impact factor: 7.727

3.  Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.

Authors:  Kenneth W Drombosky; Sascha Rode; Ravi Kodali; Tija C Jacob; Michael J Palladino; Ronald Wetzel
Journal:  Neurobiol Dis       Date:  2018-08-30       Impact factor: 5.996

4.  Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

Authors:  Anto Sam Crosslee Louis Sam Titus; Tanzeen Yusuff; Marlène Cassar; Elizabeth Thomas; Doris Kretzschmar; Santosh R D'Mello
Journal:  J Neurosci       Date:  2017-05-26       Impact factor: 6.167

5.  Structure of Membrane-Bound Huntingtin Exon 1 Reveals Membrane Interaction and Aggregation Mechanisms.

Authors:  Meixin Tao; Nitin K Pandey; Ryan Barnes; Songi Han; Ralf Langen
Journal:  Structure       Date:  2019-08-26       Impact factor: 5.006

6.  Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and Nucleocytoplasmic Transport.

Authors:  Fatima Gasset-Rosa; Carlos Chillon-Marinas; Alexander Goginashvili; Ranjit Singh Atwal; Jonathan W Artates; Ricardos Tabet; Vanessa C Wheeler; Anne G Bang; Don W Cleveland; Clotilde Lagier-Tourenne
Journal:  Neuron       Date:  2017-04-05       Impact factor: 17.173

7.  Mutant Huntingtin Disrupts the Nuclear Pore Complex.

Authors:  Jonathan C Grima; J Gavin Daigle; Nicolas Arbez; Kathleen C Cunningham; Ke Zhang; Joseph Ochaba; Charlene Geater; Eva Morozko; Jennifer Stocksdale; Jenna C Glatzer; Jacqueline T Pham; Ishrat Ahmed; Qi Peng; Harsh Wadhwa; Olga Pletnikova; Juan C Troncoso; Wenzhen Duan; Solomon H Snyder; Laura P W Ranum; Leslie M Thompson; Thomas E Lloyd; Christopher A Ross; Jeffrey D Rothstein
Journal:  Neuron       Date:  2017-04-05       Impact factor: 17.173

Review 8.  Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.

Authors:  Adewale Adegbuyiro; Faezeh Sedighi; Albert W Pilkington; Sharon Groover; Justin Legleiter
Journal:  Biochemistry       Date:  2017-02-21       Impact factor: 3.162

9.  Acetylation within the First 17 Residues of Huntingtin Exon 1 Alters Aggregation and Lipid Binding.

Authors:  Maxmore Chaibva; Sudi Jawahery; Albert W Pilkington; James R Arndt; Olivia Sarver; Stephen Valentine; Silvina Matysiak; Justin Legleiter
Journal:  Biophys J       Date:  2016-07-26       Impact factor: 4.033

Review 10.  Polyglutamine Repeats in Neurodegenerative Diseases.

Authors:  Andrew P Lieberman; Vikram G Shakkottai; Roger L Albin
Journal:  Annu Rev Pathol       Date:  2018-08-08       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.